References

Current and maximum acceptable travel times to primary care among US older adults

10.1001/jamanetworkopen.2025.45280 · 2025 · External reference

Lifetime risk and projected burden of dementia

10.1038/s41591-024-03340-9 · 2025 · External reference

Expanding the use of brief cognitive assessments to detect suspected early-stage cognitive impairment in primary care

10.1002/alz.13051 · 2023 · External reference

Expected and diagnosed rates of mild cognitive impairment and dementia in the U.S. Medicare population: observational analysis

10.1186/s13195-023-01272-z · 2023 · External reference

Dementia diagnosis disparities by race and ethnicity

10.1097/mlr.0000000000001577 · 2021 · External reference

Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission

10.1016/s0140-6736(24)01296-0 · 2024 · External reference

Structured vs self-guided multidomain lifestyle interventions for global cognitive function: the US POINTER randomized clinical trial

10.1001/jama.2025.12923 · 2025 · External reference

Effects of intensive lifestyle changes on the progression of mild cognitive impairment or early dementia due to Alzheimer’s disease: a randomized, controlled clinical trial

10.1186/s13195-024-01482-z · 2024 · External reference

Implementing early detection of cognitive impairment in primary care to improve care for older adults

10.1111/joim.20098 · 2025 · External reference

Acceptable performance of blood biomarker tests of amyloid pathology—recommendations from the global CEO initiative on Alzheimer’s disease

10.1038/s41582-024-00977-5 · 2024 · External reference

Revised criteria for diagnosis and staging of Alzheimer’s disease: Alzheimer's Association Workgroup

10.1002/alz.13859 · 2024 · External reference

Psychometric limitations of the mini-mental state examination among nondemented older adults: an evaluation of neurocognitive and magnetic resonance imaging correlates

10.1080/0361073x.2013.808109 · 2013 · External reference

Primary care detection of Alzheimer’s disease using a self-administered digital cognitive test and blood biomarkers

10.1038/s41591-025-03965-4 · 2025 · External reference

Enhancing early detection of cognitive impairment in primary care with the TabCAT-BHA

10.1002/alz.70437 · 2025 · External reference

Feasibility and acceptability of implementing a digital cognitive assessment for Alzheimer disease and related dementias in primary care

10.1370/afm.240293 · 2025 · External reference

A scoping review of remote and unsupervised digital cognitive assessments in preclinical Alzheimer’s disease

10.1038/s41746-025-01583-5 · 2025 · External reference

Unresolved reference

2024 · External reference

Acceptable standards for clinic-based digital cognitive assessments: recommendations from the global CEO initiative on Alzheimer’s disease

10.1002/alz.70966 · 2025 · External reference

Boston cognitive assessment (BOCA)—a comprehensive self-administered smartphone- and computer-based at-home test for longitudinal tracking of cognitive performance

10.1186/s12883-022-02620-6 · 2022 · External reference

The Boston cognitive assessment: psychometric foundations of a self-administered measure of global cognition

10.1080/13854046.2021.1933190 · 2022 · External reference

Validation and convergent validity of the Boston cognitive assessment (BOCA) in an Italian population: a comparative study with the Montreal cognitive assessment (MoCA) in Alzheimer’s disease spectrum

10.1007/s10072-024-07775-3 · 2024 · External reference

The Montreal cognitive assessment, MoCA: a brief screening tool for mild cognitive impairment

10.1111/j.1532-5415.2005.53221.x · 2005 · External reference

T-MoCA: a valid phone screen for cognitive impairment in diverse community samples

10.1002/dad2.12144 · 2021 · External reference

Comparative performance of the digital clock and recall™ test, Montreal cognitive assessment, and Saint Louis University mental Status among patients in primary care

10.1002/alz.079034 · 2023 · External reference

Digital clock and recall is superior to the mini-mental state examination for the detection of mild cognitive impairment and mild dementia

10.1186/s13195-023-01367-7 · 2024 · External reference

Performance of older adults on the digital clock and recall test compared to the Montreal cognitive assessment in primary care settings

10.1007/s11606-025-09702-4 · 2025 · External reference

Unsupervised high-frequency smartphone-based cognitive assessments are reliable, valid, and feasible in older adults at risk for Alzheimer’s disease

10.1017/s135561772200042x · 2023 · External reference

Psychometric and adherence considerations for high-frequency, smartphone-based cognitive screening protocols in older adults

10.1017/s1355617724000328 · 2024 · External reference

Unsupervised mobile cognitive testing for use in preclinical Alzheimer’s disease

10.1002/dad2.12243 · 2021 · External reference

Agile implementation of a digital cognitive assessment for dementia in primary care

10.1370/afm.240294 · 2025 · External reference

Lower electronic health record adoption and interoperability in rural versus urban physician participants: a cross-sectional analysis from the CMS quality payment program

10.1186/s12913-024-12168-5 · 2025 · External reference

Classification statistics of the Montreal cognitive assessment (MoCA): are we interpreting the MoCA correctly?

10.1080/13854046.2022.2086487 · 2023 · External reference

Is the Montreal cognitive assessment culturally valid in a diverse geriatric primary care setting? Lessons from the Bronx

10.1111/jgs.18705 · 2024 · External reference